Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro

Growth Hormone and IGF Research

Volumn 16, Issue 3, 2006, Pages 202-210

  Mochizuki, Tomoko ^a   Sakai, Keiji ^a   Iwashita, Mitsutoshi ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

Apoptosis; EGF; Endometrial cancer; IGFBP 3

Indexed keywords

BROXURIDINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; PROTEIN P53; SINGLE STRANDED DNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN RECEPTOR;

APOPTOSIS; ARTICLE; BIOSENSOR; CANCER CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DNA SYNTHESIS; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BIOSENSING TECHNIQUES; BROMODEOXYURIDINE; CELL MEMBRANE; CELL PROLIFERATION; DNA, SINGLE-STRANDED; ENDOMETRIAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33746272396     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.05.002     Document Type: Article

References (44)

1. Ritovos O., Ranta T., Jalkanen J., Suikkari A.-M., Voutilainen R., Bohn H., and Rutanen E.M. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 122 (1988) 2150-2157
2. Elgin R.G., Busby W.H., and Clemmons D.R. An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci. USA 84 (1987) 3254-3258
3. Jones J.I., Gockerman A., Busby W.H., Wright G., and Clemmons D.R. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA 90 (1993) 10553-10557
4. Liu L., Delbe J., Blat C., Zapf J., and Harel L. Insulin-like growth factor binding-3 (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and IGF-II. J. Cell Physiol. 153 (1992) 15-21
5. Oh Y., Muller H.L., Lamson G., and Rosenfeld R.G. Insulin-like growth factor (IGF) independent action of IGF-binding protein-3 in Hs578T human breast carcinoma cells. Cell surface binding and growth inhibition. J. Biol. Chem. 268 (1993) 964-971
6. Slootweg M.C., Ohlsson C., Salles J.P., de Vries C.P., and Netelenbos J.C. Insulin-like growth factor binding protein-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Endocrinology 136 (1995) 4210-4217
7. Cohen P., Lamson G., Okajima T., and Rosenfeld R.G. Transfection of the human IGFBP-3 gene into Balb/c fibroblasts: a model for the cellular functions of IGFBPs. Growth Regul. 3 (1993) 23-26
8. Butt A.J., Firth S.M., King M.A., and Baxter R.C. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independt radiation-induced apoptosis in human breast cancer cells. J. Biol. Chem. 275 (2000) 39174-39181
9. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., and Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377 (1995) 646-649
10. Mohseni-Zadeh S., and Binoux M. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. Endocrinology 138 (1997) 5645-5648
11. Leal S.M., Liu Q., Huang S.S., and Huang J.S. The type V transforming growth factor beta receptor is the putative insulin-like growth factor binding protein 3 receptor. J. Biol. Chem. 272 (1997) 20572-29576
12. Rajah R., Valentinis B., and Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272 (1997) 12181-12188
13. Liu B., Lee H.Y., Weinzimer S.A., Powell D.R., Clifford J.L., Kurie J.M., and Cohen P. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J. Biol. Chem. 275 (2000) 33607-33613
14. Wu H.B., Kumar A., Tsai W.C., Mascarenhas D., Healey J., and Rechler M.M. Characterization of the inhibition of DNA synthesis in proliferating mink lung epithelial cells by insulin-like growth factor binding protein-3. J. Cell Biochem. 77 (2000) 288-297
15. Conover C.A., Bale L.K., Durham S.K., and Powell D.R. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Endocrinology 141 (2000) 3098-3103
16. Stoschek C.M., and King L.E. Role of epidermal growth factor in carcinogenesis. Cancer Res. 46 (1986) 1030-1037
17. Salomon D.S., Brandt R., Ciardiello F., and Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19 (1995) 183-232
18. Chaudhary L.R., and Hruska K.A. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J. Cell. Biochem. 81 (2001) 304-311
19. Wu C.J., Chen Z., Ullrich A., Greene M.I., and O'Rourke D.M. Inhibition of EGFR-mediated phophoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal regulatory proteins (SIRPs). Oncogene 19 (2000) 3999-4010
20. Chakravarti A., Chakladar A., Delaney M.A., Latham D.E., and Loeffler J.S. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Cancer Res. 62 (2002) 4307-4315
21. Baselga J., Pfister D., and Cooper M.R. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J. Clin. Oncol. 18 (2000) 904-915
22. Hidalgo M., Siu L.L., Nemunaitis J., Rizzo J., Hammond L.A., Takimoto C., Eckhardt S.G., Tolcher A., Britten C.D., Denis L., Ferrante K., Von Hoff D.D., Silberman S., and Rowinsky E.K. Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies. J. Clin. Oncol. 19 (2001) 3267-3279
23. Robert F., Ezekiel M.P., Spencer S.A., Meredith R.F., Bonner J.A., Khazaeli M.B., Saleh M.N., Carey D., LoBuglio A.F., Wheeler R.H., Cooper M.R., and Waksal H.W. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J. Clin. Oncol. 19 (2001) 3234-3243
24. Blacque O.E., and Worrall D.M. Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J. Biol. Chem. 277 (2002) 10783-10788
25. Smith E.P., Lu L., Chernnausek S.D., and Klein D.J. Insulin-like growth factor-binding protein-3 (IGFBP-3) concentration in rat Sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans. Endocrinology 135 (1994) 359-364
26. Butt A.J., Fraley K.A., Firth S.M., and Baxter R.C. IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology 143 (2002) 2693-2699
27. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16 (1995) 3-34
28. Grimberg A., and Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J. Cell Physiol. 183 (2000) 1-9 Review
29. Clemmons D.R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev. 8 (1997) 45-62
30. Moerman E.J., Thweatt R., Moerman A.M., Jones R.A., and Goldstein S. Insulin-like growth factor binding protein-3 is overexpressed in senescent and quiescent human fibroblasts. Exp. Gerontol. 28 (1993) 361-370
31. Devi G.R., Yang D.H., Rosenfeld R.G., and Oh Y. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling. Endocrinology 141 (2000) 4171-4179
32. Rajah R., Lee K.W., and Cohen P. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. Cell. Growth. Differ. 13 (2002) 163-171
33. Adams J.M., and Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends. Biochem. Sci. 26 (2001) 61-66
34. Hollowood A.D., Lai T., Perks C.M., Newcomb P.V., Alderson D., and Holly J.M. IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int. J. Cancer 88 (2002) 336-341
35. Franklin S.L., Ferry R.J., and Cohen P. Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival. J. Clin. Endocrinol. Metab. 88 (2003) 900-907
36. Conover C.A., Bale L.K., Durham S.K., and Powell D.R. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Endocrinology 141 (2000) 3098-3103
37. Ricort J.M., and Binoux M. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. J. Biol. Chem. 277 (2002) 19448-19454
38. Carpenter G., and Cohen S. Human epidermal growth factor and the proliferation of human fibroblasts. J. Cell Physiol. 88 (1976) 227-237
39. Carpenter G., and Zendegui J.G. Epidermal growth factor, its receptor, and related proteins. Exp. Cell. Res. 164 (1986) 1-10
40. Stoscheck C.M., and King L.E. Role of epidermal growth factor in carcinogenesis. Cancer Res. 46 (1986) 1030-1037
41. Neal D.E., Marsh C., Bennett M.K., Abel P.D., Hall R.R., Sainsbury J.R., and Harris A.L. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet 16 (1985) 366-368
42. Miyakawa M., Tsushima T., Murakawa H., Wakai K., Isozaki O., and Takano K. Increased expression of phosphorylated p70S6 kinase and Akt in papillary thyroid cancer tissues. Endocrinol. J. 50 (2003) 77-83
43. Chakravarti A., Loeffler J.S., and Dyson N.J. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Cancer Res. 62 (2002) 200-207
44. Martin J.L., Weenink S.M., and Baxter R.C. Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells, involvement of p44/42 and p38 mitogen-activated protein kinases. J. Biol. Chem. 278 (2003) 2969-2976